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Human herpesvirus-6A (HHV-6A) and 6B (HHV-6B) are two closely related betaherpesviruses 
that are associated with various diseases including seizures and encephalitis. The 
HHV-6A/B genomes have been shown to be present in an integrated state in the telomeres 
of latently infected cells. In addition, integration of HHV-6A/B in germ cells has resulted 
in individuals harboring this inherited chromosomally integrated HHV-6A/B (iciHHV-6) in 
every cell of their body. Until now, the viral transcriptome and the epigenetic modifications 
that contribute to the silencing of the integrated virus genome remain elusive. In the current 
study, we used a patient-derived iciHHV-6A cell line to assess the global viral gene 
expression profile by RNA-seq, and the chromatin profiles by MNase-seq and ChIP-seq 
analyses. In addition, we investigated an in vitro generated cell line (293-HHV-6A) that 
expresses GFP upon the addition of agents commonly used to induce herpesvirus 
reactivation such as TPA. No viral gene expression including miRNAs was detected from 
the HHV-6A genomes, indicating that the integrated virus is transcriptionally silent. 
Intriguingly, upon stimulation of the 293-HHV-6A cell line with TPA, only foreign promoters 
in the virus genome were activated, while all HHV-6A promoters remained completely 
silenced. The transcriptional silencing of latent HHV-6A was further supported by 
MNase-seq results, which demonstrate that the latent viral genome resides in a highly 
condensed nucleosome-associated state. We further explored the enrichment profiles of 
histone modifications via ChIP-seq analysis. Our results indicated that the HHV-6 genome 
is modestly enriched with the repressive histone marks H3K9me3/H3K27me3 and does 
not possess the active histone modifications H3K27ac/H3K4me3. Overall, these results 
indicate that HHV-6 genomes reside in a condensed chromatin state, providing insight 
into the epigenetic mechanisms associated with the silencing of the integrated 
HHV-6A genome.
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INTRODUCTION
Human herpesvirus 6 (HHV-6) was first discovered in patients 
with lymphoproliferative disorders (Salahuddin et  al., 1986) and 
has a seroprevalence of more than 90% (Zerr et  al., 2005). Since 
then, two variants were identified termed HHV-6A and HHV-6B, 
which have been classified as two distinct species based on their 
biological, immunological, and molecular properties (Adams and 
Carstens, 2012; Ablashi et  al., 2014). Infection with HHV-6B 
occurs within the first 2  years of life and is the primary cause 
of Roseola infantum, a febrile illness with a skin rash that can 
be  accompanied by seizures, meningoencephalitis, and 
encephalopathy (Yamanishi et  al., 1988; De Bolle et  al., 2005). 
The pathologies associated with HHV-6A remain poorly 
characterized, although a recent report has suggested an association 
between HHV-6A and Alzheimer’s disease (Readhead et al., 2018).
Upon primary infection, HHV-6A/B establishes a lifelong 
persistent infection in the host, termed latency (Takahashi et al., 
1989; Lusso et  al., 1991). In latently infected cells, both viruses 
integrate their genome into the telomere region of host 
chromosomes (Arbuckle et  al., 2010, 2013). This integration is 
facilitated by telomeric repeats (TTAGGG)n at the ends of the 
virus genome (Kaufer et  al., 2011; Kaufer and Flamand, 2014; 
Wallaschek et al., 2016); however, the viral and/or cellular proteins 
that mediate integration remain elusive. Aside from latently 
infected cells, both viruses can also integrate their genomes into 
germ cells. This allows vertical transmission of HHV-6A/B and 
consequently individuals harbor the integrated virus in every 
cell of their body (Pellett et  al., 2012). Approximately 1% of 
the human population has this condition termed inherited 
chromosomally integrated HHV-6A/B (iciHHV-6) (Pellett et  al., 
2012). The clinical consequences for iciHHV-6 patients remain 
poorly understood. An analysis of a large cohort revealed that 
iciHHV-6 patients have an increased risk of developing angina 
pectoris and other diseases (Gravel et al., 2015), but more research 
is needed to provide a better understanding of these disease 
associations. Reactivation of HHV-6A/B is associated with a 
number of diseases including encephalitis, multiple sclerosis, and 
graft rejection following transplantation (De Bolle et  al., 2005; 
Caselli and Di Luca, 2007). For example, reactivation occurs in 
30–70% of hematopoietic stem cell transplantation (HSCT) 
recipients and is linked to graft rejections and higher mortality 
(Vinnard et  al., 2009; Hill and Zerr, 2014; Winestone et  al., 
2018). In addition, a higher frequency and severity of both 
graft-versus-host disease (GvHD) and cytomegalovirus (CMV) 
viremia were observed in HSCT patients when either the recipient 
or donor were iciHHV-6 positive (Hill et  al., 2017).
Analysis of iciHHV-6 cell lines by RT-qPCR revealed that 
few or none of the assessed genes are expressed from the integrated 
virus genome (Strenger et al., 2014), suggesting that the integrated 
genome is efficiently silenced. Epigenetic modifications likely 
contribute to this silencing and will be the focus of this manuscript. 
Chromatin dynamics are largely mediated by a variety of post-
translational modifications of the N-terminal tail of histone 
proteins, which promotes either an active or repressive 
transcriptional state. Modifications such as trimethylation (me3) 
of lysine 4 (K4) of histone 3 (H3K4me3), and acetylation (ac) 
of lysine 27 (K27) of histone 3 (H3K27ac), are often associated 
with less condensed chromatin referred to as the transcriptionally 
active euchromatin. On the other hand, modifications such as 
H3K27me3 and H3K9me3 are often associated with highly 
condensed chromatin and a repressive transcriptional state referred 
to as heterochromatin (Berger, 2007; Li et  al., 2007). 
Heterochromatin formation and nucleosomal occupancy have 
been linked to viral latency for herpes simplex virus 1 (HSV-1) 
(Deshmane and Fraser, 1989; Kubat et  al., 2004; Wang et  al., 
2005; Knipe and Cliffe, 2008; Cliffe et  al., 2009; Bloom et  al., 
2010), Epstein-Barr virus (Dyson and Farrell, 1985; Shaw, 1985; 
Moquin et al., 2018), and human immunodeficiency virus (HIV) 
(Jordan et  al., 2003; du Chéné et  al., 2007; Friedman et  al., 
2011). However, the epigenetic modifications that contribute to 
the silencing of integrated (latent) HHV-6A/B remain unknown.
In the current study, we  employed unbiased genomic 
approaches using RNA-, MNase-, and ChIP-sequencing to 
explore the state of the viral genome in patient-derived iciHHV-6 
and experimentally infected 293-HHV-6A cells. Our data reveal 
that integrated HHV-6A is entirely transcriptionally silent and 
exists in a highly condensed, nucleosome-associated state. 
Further, the repressive histone modifications H3K9me3 and 
H3K27me3 were detected across the HHV-6A genome, although 
both histone modifications were not significantly enriched. 
Additionally, the latent genome lacks the active histone 
modifications H3K27ac and H3K4me3. These results provide 
the first chromatin landscape of the integrated HHV-6A genome 
in experimentally infected and iciHHV-6 patient-derived cells.
MATERIALS AND METHODS
Cell Lines and Virus
Following approval by the CHU de Quebec-Université Laval 
ethics review board and patients consent, umbilical cords of 
women undergoing C-section were tested for the presence of 
iciHHV-6A as described previously (Gravel et al., 2015). Smooth 
muscle cells (SMCs) were obtained from the arteries of 
iciHHV-6A+ umbilical cords as described (Moreau et  al., 2007) 
and immortalized by transduction with a lentiviral vector 
expressing SV40 T antigens (Addene #22298). Human SMCs 
(iciHHV-6A) were cultured in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 20% fetal bovine serum (FBS), 
1% penicillin–streptomycin (Pen/Strep), and 1% L-Glutamine. 
Human epithelial kidney 293  T (293  T, ATCC CRL-11268) 
cells were cultured in the same medium but supplemented with 
10% FBS. All cells were maintained in 10 cm2 flasks as a 
monolayer culture in a humidified 5% CO2 air incubator at 
37°C. Bacterial artificial chromosome (BAC)-derived HHV-6A 
(strain U1102) expressing green fluorescent protein (GFP) under 
the control of the HCMV major immediate early (IE) promoter 
(HHV-6-GFP) was propagated in JJHan cells as described 
previously (Tang et  al., 2010). 293  T cells were infected with 
HHV-6-GFP and GFP positive cells were isolated using a FACS 
AriaIII cell sorter (BD Biosciences). Clones harboring the 
integrated HHV-6A genome (293-HHV-6A) were identified by 
quantitative PCR (qPCR) and confirmed by fluorescent in situ 
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hybridization (FISH). To investigate whether expression of genes 
from the integrated virus can be  induced, clonal 293-HHV-6A 
cells were treated with either phorbol 12-myristate 13 acetate 
(TPA, Sigma) (10 ng/ml), Trichostatin A (TSA, Sigma) (0.25 μM), 
sodium butyrate (NaBy, Sigma) (3 mM), Etoposide (ETP, Sigma) 
(0.5  μM), suberoylanilide hydroxamic acid (SAHA; also known 
as vorinostat, Sigma) (1  μM), Forskolin (FSK, Sigma) (10  μM), 
or hydrocortisone (Dexamethasone, Dexa) (10  μM) for 24  h. 
Reactivation of HHV-6A was monitored using FACS Calibur 
(BD Biosciences) to determine the percent of GFP positive 
(GFP+) cells.
Fluorescent in situ Hybridization
To prove that HHV-6A genome is present at the ends of metaphase 
chromosomes, FISH was performed as described previously (Rens 
et al., 2006; Kaufer et al., 2011; Kaufer, 2013). Briefly, cell cultures 
were treated with 0.05  μg/ml colcemid (Gibco) overnight to 
arrest the cells in metaphase. Cells were collected by centrifugation, 
resuspended in hypotonic solution (0.075  M KCl) followed by 
methanol/acetic acid fixation and stored at −20°C until further 
use. Metaphase spreads were generated as described previously 
(Kaufer et  al., 2011). The virus genome was detected using a 
HHV-6A-specific digoxigenin-labeled probe and detected using 
different antibodies as described by Wight et  al. (2018). Slides 
were mounted using DAPI Vectashield (Vector Laboratories) and 
images taken with an Axio Imager M1 (Zeiss).
Quantitative PCR
HHV-6 genome copies were determined by qPCR using specific 
primers and TaqMan probes for U94 as described previously 
(Wallaschek et  al., 2016). Briefly, DNA was isolated using the 
RTP® DNA/RNA Virus Mini Kit (Stratec) according to 
manufacturer’s instructions. U94 gene copy numbers were 
normalized against the genome copies of the cellular ß2M gene 
and compared to a control cell line (AP3) harboring one copy 
of the HHV-6A genome per cell (Gravel et  al., 2017).
RT-qPCR
For HHV-6A transcriptome quantification, cells were treated 
with TPA during 6  days and RNA was isolated using the 
RNeasy Plus Mini Kit (Qiagen) according to manufacturer’s 
instructions. Total RNA was reverse transcribed to single-stranded 
cDNA using High-Capacity cDNA Reverse Transcription Kit 
(Applied Biosystems) according to manufacturer’s instructions. 
qPCR was performed using TaqMan probes for immediate-early 
(U86, U90) and early genes (U41, U70) as described previously 
(Wight et  al., 2018). Gene copy numbers were normalized 
against the genome copies of the cellular ß2M gene.
RNA-seq
RNA was extracted from patient-derived iciHHV-6 cells using 
Trizol Reagent (Life Technologies) and purified using Direct-zol 
RNA MicroPrep Kit (Zymo Research #R2060) following the 
manufacturer’s instructions. In addition, RNA was isolated and 
purified from in vitro generated HHV6-GFP cells treated with 
either DMSO or 10  ng/ml phorbol 12-myristate 13 acetate 
(TPA, Sigma) for 24  h at 37°C in duplicate. One microgram 
of total RNA was depleted of ribosomal RNA (rRNA) using 
the KAPA RiboErase Kit (#KR1142) and libraries were prepared 
using the KAPA Stranded RNA-seq Library Preparation Kit 
(#KR0934). Libraries were quantified using Qubit (Life 
Technologies), and quality was assessed using the Agilent 
Bioanalyzer High-Sensitivity DNA kit (Agilent Technologies). 
Barcoded libraries were pooled and sequenced on an Illumina 
HiSeq 2,500 at the Genomics Core Facility (University of Texas 
Health Science Center, San Antonio, TX) to obtain 50-bp 
single-end reads. RNA-seq data were processed using TopHat 
as described previously (Trapnell et  al., 2009) using human 
(hg38), HHV-6A (NC_001664.2) and the custom HHV-6A-GFP 
BAC genome. BAM files were sorted and converted to SAM 
files using SAMtools (Li et  al., 2009) and reads were counted 
with HTSeq against the corresponding Gencode GTF files 
(Anders et  al., 2015). Differential analysis of RNA-seq count 
data between TPA- and DMSO-treated cells was performed 
using DESeq2 (Love et  al., 2014) with a gene false discovery 
rate of <0.5% (FDR  <  0.005) and a fold change >2 considered 
as significantly different. RNA-seq datasets were visualized using 
the Integrated Genome Browser (Nicol et  al., 2009).
MicroRNA-seq
RNA was extracted and purified from iciHHV-6A, and TPA 
or DMSO treated 293-HHV-6A cells as described above. 
MicroRNA (miRNA) libraries were prepared using NEBNext 
Multiplex Small RNA Sample Prep for Illumina (#E7300) following 
the manufacturer’s protocol. Library quantification and quality 
were assessed as described above, and pooled libraries were 
sequenced on an Illumina HiSeq 2,500 at the Genomics Core 
Facility (University of Texas Health Science Center, San Antonio, 
TX) to obtain 50-bp single-end reads. miRNA data were processed 
using the Oasis2 package (Rahman et  al., 2018).
Micrococcal Nuclease-seq
Micrococcal nuclease (MNase)-seq was performed using the EZ 
Nucleosomal DNA Prep Kit (Zymo Research #D5220) following 
the manufacturer’s protocol. Briefly, nuclei isolated from 1 million 
iciHHV-6A and 293-HHV-6A cells were treated with varying 
concentrations of MNase (final concentrations of 0.07, 0.1, 0.2, 
0.3  U/100  μl reaction) and incubated at room temperature for 
5  min. The reaction was terminated with MNase stop buffer, 
and following nucleosomal DNA purification, libraries for each 
individual titration were prepared with the NEB Ultra II Library 
Prep Kit (#E7645S) following the manufacturer’s protocol. Libraries 
were purified using 0.8X AMPure beads and quantified using 
Qubit (Life Technologies). Library quality and presence of mono-, 
di-, and tri-nucloesomes were observed using the Agilent 2,100 
Bioanalyzer High-Sensitivity DNA kit. Barcoded libraries were 
pooled and sequenced on an Illumina HiSeq 2,500 instrument 
lane at the Genomics Core Facility (University of Texas Health 
Science Center, San Antonio, TX) to obtain 80-bp paired-end 
reads. Sequences were aligned to the human (hg38), HHV-6A 
(NC_001664.2), and custom HHV-6A-GFP genome using Bowtie2 
(Langmead and Salzberg, 2012), and the bamCoverage command 
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in deepTools was used to filter out reads with insert sizes <50 bp 
and  >500  bp and to generate bigwigs (Ramírez et  al., 2016). 
Profiles were generated for individual titration points, and as 
it has been previously reported that nucleosome occupancy can 
change across the genome in response to MNase treatment 
(Maehara and Ohkawa, 2016; Mieczkowski et  al., 2016; Mueller 
et  al., 2017), data for each titration were merged based on the 
cell line. Data were processed using DANPOS as described 
previously (Chen et  al., 2013).
Chromatin Immunoprecipitation
The antibodies used for ChIP-seq experiments were: histone H3 
[#2650 (Cell Signaling Technologies)], H3K4me3 [#8580 (Abcam, 
lot GR273043)], H3K27ac [#4729 (Abcam, lot GR288020)], 
H3K27me3 [#6002 (Abcam, lot GR275911-4)], H3K9me3 [#8898 
(Abcam, lot GR21638-1)], and control IgG [#171870 (Abcam)]. 
ChIP sequencing was performed as described previously (O’Geen 
et  al., 2010) on the iciHHV-6A cell lines. For all antibodies, 
20 μg of chromatin was incubated with 4 μl of antibody overnight 
at 4°C. The complexes were precipitated with 20  μl of Pierce™ 
Protein A/G Magnetic Beads, followed by extensive washing, 
and final elution of the immunoprecipitated chromatin complexes 
in 100 μl of ChIP elution buffer for subsequent DNA purification 
and library construction. Libraries were prepared using the 
NEBNext ChIP-Seq Library Prep Master Mix Set for Illumina 
(#E6240) following the manufacturer’s instructions. Library 
concentration and quality were assessed on a Qubit (Life 
Technologies) and an Agilent 2,100 Bioanalyzer, respectively. 
Pooled libraries were sequenced on an Illumina HiSeq 2,500 
instrument lane at the Genomics Core Facility (University of 
Texas Health Science Center, San Antonio, TX) to obtain 50-bp 
single-end reads. Sequence reads were aligned to the human 
(hg38) and HHV-6A (NC_001664.2) genomes using Bowtie2 
(Langmead and Salzberg, 2012). The resulting SAM alignment 
files were used for peak calling using MACS2 against the control 
(no antibody) inputs (Zhang et  al., 2008) and using default 
parameters. ChIP DNA assayed by quantitative PCR is expressed 
as fold enrichment over an internal control (GAPDH) and is 
normalized to input. Primers for ChIP-qPCR are listed in Table 3.
RESULTS
Gene Expression Profiling of Integrated 
HHV-6A Genomes
To determine the gene expression of integrated HHV-6A genomes, 
we employed a global RNA-seq approach using clonal iciHHV-6A 
patient cells (iciHHV-6A) and an in vitro generated cell line 
(293-HHV-6A). The latter cell model was obtained by infecting 
293  T cells with HHV-6A expressing GFP under the control 
of the major immediate-early (IE) HCMV promoter. Presence 
of the HHV-6A genome in both cell lines was confirmed by 
qPCR and FISH analyses (Figures 1A,B). To assess gene expression, 
we  collected total RNA from latent cell cultures, constructed 
stranded rRNA-depleted Illumina RNA-seq libraries and mapped 
the reads to the human and the HHV-6A reference genomes. 
Characteristic of a typical RNA-seq profile, we  detected a range 
of host cellular transcripts with RPKM (reads per kb per million 
mapped) values ranging from 1 to >1,000 RPKM in both 
iciHHV-6A (Supplementary Figure S1A) and 293-HHV-6A cell 
lines (Supplementary Figure S1B, DMSO treatment). Surprisingly, 
when our data were mapped to the HHV-6A reference genomes, 
we  failed to detect any previously determined viral latency-
associated transcripts in both HHV-6A cell lines with all RPKM 
A B
FIGURE 1 | Detection of HHV-6A genome at the end of methaphase chromosomes of iciHHV-6 and 293-HHV-6A cell lines. (A) HHV-6A (U94) genome copy 
numbers were detected by qPCR. Copy numbers per million cells are shown as means of three independent experiments with standard deviation. AP3 (HHV-6A) 
cells were used as a control. Copy numbers were normalized to AP3 cells carrying one HHV-6A copy per cell. (B) HHV-6A genome visualized by FISH. 
Representative metaphase images of iciHHV-6A (upper panel) and 293-HHV-6A (lower panel) cell lines. The HHV-6A genome was detected using a specific  
DIG-labeled probe (green) and chromosomes were visualized using DAPI (gray). Scale bar corresponds to 10 μm.
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values <1.0. To confirm that the absence of transcripts was not 
due to major changes in the virus genome, we performed whole 
genome sequencing and genome-guided assembly. No deletion 
or mutations were observed that would explain the complete 
absence of viral transcripts. These results demonstrate a tight 
silencing of the entire HHV-6A genome in both patient-derived 
and an in vitro generated cell line.
Upon treatment of the 293-HHV-6A cell line with common 
reagents that induce reactivation (Supplementary Figure S2), 
greater than 90% of the TPA-treated cells express GFP while 
fewer than 1% express GFP in the DMSO-treated control 
(Figure 2A). Therefore, we set to determine how TPA treatment 
affects the global expression profile of the virus genome in 
293-HHV-6A cells as described above. As expected, TPA induced 
global changes on human gene expression compared to the 
control (Supplementary Figures S1B–D). However, only the 
foreign HCMV IE and HSV-1 TK promoters driving GFP and 
EcoGPT respectively were induced in the HHV-6A genome, 
while all HHV-6A promoters remained silent (Figure 2B). To 
confirm this observation, we assessed the expression of selected 
viral genes following TPA induction for an extended period 
of time by RT-qPCR (Supplementary Figure S2B). Our data 
show that foreign but not HHV-6A promoters are efficiently 
induced by TPA, suggesting a selective activation by this 
activation stimulus.
Since viral encoded miRNAs play a pivotal role in the viral 
life cycle and latency of other herpesviruses, we also investigated 
the miRNA expression of these cells by small RNA-seq analysis. 
We performed small RNA-seq analysis using the patient-derived 
and experimental infected models (treated with TPA or DMSO 
control). Following adapter removal, we obtained a high number 
of reads that uniquely align to the human reference genome, 
the majority of these reads being identified as miRNAs 
(Supplementary Figure S3). No HHV-6A-derived miRNAs 
were identified in any of the libraries, indicating that HHV-6A 
does not express miRNAs in the cell lines we  have tested. 
Taken together, our results suggest that both in vitro generated 
and patient-derived iciHHV-6A cells are transcriptionally silent. 
Moreover, this demonstrates that TPA stimulation fails to 
efficiently activate the HHV-6A promoters while foreign 
promoters in the viral genome are activated.
Chromosomally Integrated HHV-6A Is 
Associated With Nucleosomes
To better understand the transcriptional silencing observed from 
integrated HHV-6A, we  examined the association of the virus 
genome with nucleosomes. Nucleosome positioning and occupancy 
profoundly influence gene expression (Li et  al., 2007; Jiang and 
Pugh, 2009). Therefore, mapping the genomic location of 
nucleosomes is critical for understanding the mechanisms of 
chromatin-mediated transcriptional regulation. A commonly used 
approach is MNase-seq, in which nucleosome-free regions of 
chromatin are digested with MNase leaving nucleosome-associated 
DNA intact (Cui and Zhao, 2012; Mieczkowski et al., 2016; Pajoro 
et  al., 2018). Mapping these data to a reference genome allows 
for a genome-wide profiling of nucleosome occupancy.
To profile the nucleosomal landscape of latent HHV-6A, 
we performed MNase-seq on non-TPA-treated ciHHV-6 samples 
with four different MNase concentrations (0.07, 0.1, 0.2, and 
0.3  U). MNase-seq reads were aligned to both the human 
(hg38) and HHV-6A reference genomes (Table 1) and 
we  determined the distribution of nucleosome occupancy 
around the transcription start sites (TSSs), which are 
nucleosome-free regions of the genome (Buenrostro et  al., 
2013; Mieczkowski et  al., 2016). As previously demonstrated, 
there is decreased nucleosome signal at all active TSSs across 
A
B
FIGURE 2 | TPA stimulation fails to reactivate in vitro chromosomally integrated HHV-6A. (A) 293-HHV-6A cells were treated with TPA or DMSO for 24 h. GFP 
expression was measured by flow cytometry. Mean of the % of GFP+ cells from two independent experiments is shown. (B) RNA was extracted from DMSO- or 
TPA-treated 293-HHV-6A cells and strand-specific RNA-seq libraries were generated. Alignment to the HHV-6A-GFP genome revealed that only transcripts 
associated with the GFP and the EcoGPT regions of the recombinant genome are detectable following TPA stimulation.
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the human genome for each of the four MNase titrations, 
and for the merged datasets (Figures 3A,B; Maehara and 
Ohkawa, 2016; Mieczkowski et  al., 2016). In contrast, the 
MNase-seq data revealed that the HHV-6A genome has limited 
MNase accessibility (Figures 3C,D), indicating that in both 
HHV-6A cell lines, the majority of the viral genome is in 
a highly compacted heterochromatin state. Further, the GFP 
and EcoGPT regions of the 293-HHV-6A cell lines also exhibit 
a nucleosome-dense, heterochromatic formation (Figure 3E), 
which correlates with the lack of observable GFP in the 
untreated cells (Figure 2A). Overall, our results suggest that 
all major regions reside in a highly condensed nucleosome-
associated state that likely contributes to the transcriptionally 





FIGURE 3 | Latent chromosomally integrated HHV-6A is associated with nucleosomes. The genome-wide distribution of the average nucleosomal occupancy in 
patient-derived iciHHV-6A and in vitro infected 293-HHV-6A cell lines. (A,B) Alignment to all transcription start sites (TSSs) for the human genome (hg38). For both 
cell lines, there is decreased nucleosome signal at all active TSSs across the hg38 genome for the four MNase titrations (0.07, 0.1, 0.2, 0.3 U), and for the merged 
datasets, validating our MNase-seq experiments. (C,D) Alignment to all open reading frame (ORF) start sites of the (C) iciHHV-6A (NC_001664.2) and 293-HHV-6A 
(D) genomes, respectively. Both cell lines demonstrate enriched nucleosome signal downstream and upstream from all ORF start sites found throughout the  
HHV-6A genome. (E) A zoomed-in snapshot showing nucleosomal enrichment across the 293-HHV-6A GFP and EcoGPT regions.
TABLE 1 | MNase-seq alignment statistics for both iciHHV-6A and 293-HHV-6A 
cell lines.
iciHHV-6A Total reads Mapped to hg38 Mapped to HHV-6A
0.07 U 108,672,380 104,671,364 3,119
0.1 U 129,284,350 123,825,376 3,842
0.2 U 115,427,930 107,820,045 3,030
0.3 U 139,973,048 130,960,010 3,905
293-HHV-6A
0.07 U 115,412,822 110,409,085 5,635
0.1 U 117,406,422 109,932,492 5,777
0.2 U 110,616,804 100,882,910 5,766
0.3 U 91,897,360 74,527,515 3,957
iciHHV-6A sequences were mapped to the HHV-6A (NC_001664.2) genome, whereas 
293-HHV-6A sequences were aligned to a custom HHV-6A genome.
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Repressive Histone Modifications  
Are Detected Across the Latent  
iciHHV-6A Genome
Mounting evidence indicates that regulatory histone modifications 
play central roles in viral latency and chromatin structure, 
including for both HSV-1 and HIV (Kubat et  al., 2004; du 
Chéné et  al., 2007). The density of nucleosome seeding of the 
integrated HHV-6A genome suggests that the virus may 
be  associated with repressive histone modifications. Therefore, 
to identify potential epigenetic modifications that may regulate 
gene expression of the HHV-6A genome, we  assayed the 
distribution of representative active (H3K27ac and H3K4me3) 
and repressive (H3K9me3 and H3K27me3) histone marks by 
a genome-wide ChIP-seq analysis in the patient-derived iciHHV-6 
cell line. ChIP-seq reads were mapped to the HHV-6A genome 




FIGURE 4 | ChIP enrichment profiles of histone modifications across the iciHHV-6A and human genomes. (A) The ChIP-seq enrichment patterns of two active 
(H3K27ac and H3K4me3) and two repressive modifications (H3K9me3 and H3K27me3) aligned to the HHV-6A (NC_001664.2) genome. The scale represents the 
fold enrichment of ChIP over input. (B) The ChIP-seq enrichment patterns of histone modification ChIP-seq datasets aligned to the human (hg38) genome. The 
ChIP-seq binding patterns demonstrate a typical profile of broad enrichment patterns of H3K27me3 and H3K9me3 in regions devoid of the active histone marks 
H3K27ac and H3K4me3. The locus at the indicated region of chromosome 2 of the hg38 human genome in mega base pairs is shown (Mb). (C) ChIP-qPCR assays 
using primers targeting HHV-6 gene regions U3, U11, U44, U52, U79, U95 and the cellular gene regions HOXA10 and ZNF180. Chromatin was immunoprecipitated 
with nonspecific IgG, total histone H3, H3K9me3, or H3K27me3 antibodies. Data are shown as the fold-enrichment over GAPDH normalized by input from three 
independent ChIP assays (mean ± SD).
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No enrichment of the active H3K27ac and H3K4me3 histone 
marks was detected across the HHV-6A genome (Figure 4A) 
as compared to the human genome (Figure 4B). In addition, 
the two repressive histone modifications H3K9me3 and 
H3K27me3 appeared to be present, but not significantly enriched 
compared to the input controls following peak calling using 
different peak calling algorithms with a range of parameters. 
This result may be  due to the low number of overall reads 
mapped to the viral genome (Table 2). To further validate 
these findings, we performed ChIP-qPCR using primers specific 
to several HHV-6A genomic regions (Table 3). The repressive 
marks H3K9me3 or H3K27me3 are enriched over nonspecific 
IgG or pan-histone H3 antibodies, albeit at lower levels than 
cellular regions (Figure 4C). Taken together, these results suggest 
that the repressive histone modifications H3K9me3 and 
H3K27me3 are present on the latent virus genome and may 
be  involved in chromatin-mediated repression of integrated 
HHV-6A gene expression.
DISCUSSION
HHV-6A/B has been shown to integrate its genomes into the 
telomere region of latently infected cells, while most other 
human herpesviruses maintain their genomes as 
extrachromosomal circular episomes during latency (Grinde, 
2013). Latent episomal herpesvirus genomes are usually 
epigenetically silenced during latency; however, the transcriptional 
activity and epigenetic state of the telomere-integrated HHV-6A/B 
genome remain poorly characterized. In the current study, 
we used unbiased genomic methodologies to analyze viral gene 
expression and the epigenetic state of the latent HHV-6A 
genome in patient-derived and in vitro infected cell lines. Our 
work provides several lines of evidence that the latent HHV-6A 
genome is maintained in a transcriptionally silent and highly 
compacted state, associated with the repressive histone 
modifications H3K9me3 and H3K27me3. Overall, these findings 
further advance our understanding of the chromatin-based 
mechanisms regulating HHV-6A gene expression and latency.
Although previous studies have linked low levels of viral 
transcripts to herpesvirus latency (Collins-McMillen and 
Goodrum, 2017), our RNA-seq analysis demonstrates that viral 
associated transcripts were not detected from the integrated 
HHV-6A genome in both iciHHV-6A and 293-HHV-6A cells. 
A previous study described four HHV-6B latency-associated 
transcripts (LATs) in latently infected cells (Kondo et al., 2002); 
however, these LATs were barely detectable in a more sensitive 
assay and showed maximal expression during the establishment 
of latency, and just before the onset of reactivation both in 
vivo and in vitro (Kondo et  al., 2003). Therefore, the detection 
of HHV-6A LATs may be  dependent on specific time points 
assayed, as we  were unable to detect any HHV-6A-associated 
transcripts in both in vitro generated and iciHHV-6 patient 
cell lines. Furthermore, only the U94 gene was transcribed in 
freshly isolated peripheral blood mononuclear cells from 
HHV-6A-infected adults and in vitro infected cells, whereas 
other viral transcripts were not detected (Rotola et  al., 1998). 
For alphaherpesviruses, HSV latency is associated with the 
expression of LATs in some latently infected neurons; however, 
LAT equivalent transcripts are not expressed in varicella zoster 
virus (VZV) latency (Kinchington et  al., 2012), although a 
recently discovered latency transcript antisense of ORF61 has 
been reported (Depledge et  al., 2018). Varying degrees of 
evidence on LATs in both natural HCMV infection and 
experimental latency models have been reported (Cheng et  al., 
2017; Shnayder et al., 2018), suggesting that herpesvirus latency 
may be  more complex and dynamic than previously assumed 
(Goodrum, 2016; Collins-McMillen and Goodrum, 2017).
The lack of viral associated miRNAs for both iciHHV-6A 
and 293-HHV-6A cells was a somewhat surprising result as 
viral miRNAs have been associated with herpesvirus latency, 
and have been shown to regulate the switch between latency 
and lytic replication (Skalsky and Cullen, 2010; Cullen, 2011; 
Piedade and Azevedo-Pereira, 2016). Latency-expressed miRNAs 
from HSV-1, EBV, and KSHV have been shown to target IE 
genes and thereby suppress lytic replication to maintain latency 
(Murphy et al., 2008; Skalsky and Cullen, 2010). Latency-specific 
viral miRNAs were also identified after deep sequencing of 
trigeminal ganglia latently infected with HSV-1; however, and 
similar to the results reported here, miRNAs have not been 
detected during VZV latency (Umbach et al., 2009). For HHV-6A 
and HHV-6B, virus-encoded miRNAs have been characterized 
in lytically infected cells (Tuddenham et al., 2012; Nukui et al., 
2015). In a recent study, Prusty et  al. (2018) was able to detect 
various viral sncRNAs in TSA-treated cells by Northern blotting, 
however, in the absence of detectable viral protein production 
or replication. Therefore, we  hypothesized that viral associated 
transcripts, including LATs and miRNAs, would be  detected 
upon reactivation of HHV-6A in 293-HHV-6A cells. RNA- and 
miRNA-seq following TPA stimulation, however, revealed that 
only transcripts associated with the GFP and EcoGPT regions 
were detected in our in vitro infected cells. Viral genes remained 
TABLE 2 | ChIP-seq alignment statistics for the iciHHV-6A cell line.
iciHHV-6A Total reads Mapped to hg38 Mapped to HHV-6A
H3K4me3 16,934,452 15,997,762 342
H3K27ac 26,765,754 24,673,031 2,379
H3K9me3 9,538,766 8,845,283 1,443
H3K27me3 22,923,694 22,382,904 492
Sequences were mapped to the HHV-6A (NC_001664.2) genome using Bowtie2.
TABLE 3 | ChIP-qPCR primers.
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below the detection limit of RNA-seq. The increased GFP 
expression suggests that TPA does not stimulate transcription 
of HHV-6A genes, and only the foreign viral promoters in 
the BAC sequence are expressed in the HHV-6-GFP genome. 
Along with this, Liu et  al. (2010) showed that TPA reverses 
HCMV MIE gene silencing via a PKC-delta-dependent 
mechanism in human NT2 cells. HHV-6 reactivation and 
associations with diseases have previously been observed in 
patients (Gravel et  al., 2013; Endo et  al., 2014; Politikos et  al., 
2018). Reactivation of the virus genome using various compounds 
in vitro can result in viral gene expression; however, these 
stimuli were not sufficient to induce the production of infectious 
particles in several in vitro infected cells (Arbuckle et al., 2010; 
Gravel et  al., 2017; Prusty et  al., 2018). Through co-cultivation 
studies, Arbuckle et al. (2010) demonstrated that the integrated 
genome in TPA- and Dexamethason-treated PBMCs from 
different iciHHV-6 individuals can be  transmitted to Molt-3 
cells. This observation may support the hypothesis that, in 
contrast to cells directly ex vivo, the HHV-6A genome in 
immortalized cell lines might be  harder to reactivate. Taken 
together, the ability and efficiency of reactivation appear to 
be  dependent on the cell type, cell line, and drug used to 
stimulate reactivation.
The lack of viral gene expression in our iciHHV-6A and 
293-HHV-6A models suggests that a chromatin-mediated 
mechanism could be  involved in transcriptional silencing of 
integrated HHV-6A. Using MNase-seq, we  profiled the 
nucleosomal positioning across the HHV-6A genome. Results 
presented here demonstrate a significant decrease in MNase 
accessibility, which is attributed to increased nucleosomal 
occupancy across the majority of the viral genome. These results 
strongly suggest that the latent virus resides in a highly compacted 
state, which would exclude the necessary transcriptional 
machinery required for gene expression. Furthermore, ChIP 
assays (ChIP-seq and ChIP-qPCR) indicate that active chromatin 
marks (H3K4me3 and H3K27ac) were not detected above 
background levels in these experiments (Figure 4A), despite 
H3K27ac having the highest amount of total mapped reads 
(Table 2). Human telomeres are enriched for H3K27ac (Cubiles 
et  al., 2018); therefore, the high number of mapped reads to 
HHV-6A, in the absence of H3K27ac enrichment, is likely 
due to non-unique reads mapping to the viral telomeric repeats. 
In contrast, H3K9me3 and H3K27me3 levels are relatively low 
in human telomeres (O’Sullivan et  al., 2010; Ichikawa et  al., 
2015; Cubiles et  al., 2018), and these repressive histone 
modifications show modest enrichment across the HHV-6A 
genome. As opposed to H3K4me3 and H3K27ac, H3K9me3 
and H3K27me3 are characterized by broad low-level enrichment 
patterns rather than sharp, clearly enriched peaks. On viruses, 
peak calling is often difficult to achieve with these marks, 
making it difficult to distinguish enriched regions from noisy 
and possibly under sampled data. While the quality of repressive 
histone ChIP-seq experiments is affected by several experimental 
parameters including sonication efficiency and sequencing depth, 
reaching ideal experimental parameters and comparable data 
quality across experiments is often difficult, costly, or even 
impossible, resulting in low sensitivity and specificity of 
measurements (Jung et  al., 2014). Importantly, conducting 
ChIP-qPCR with primers specific to several HHV-6A genomic 
regions confirms H3K9me3 and H3K27me3 enrichment, albeit 
at lower levels than cellular regions, further suggesting that 
these repressive histone modifications are a mechanism regulating 
HHV-6A latency. Interestingly, HSV or VZV infection also 
results in the deposition of nucleosomes carrying H3K9me3 
along the viral genome (Silva et  al., 2008; Kwiatkowski et  al., 
2009; Liang et  al., 2009), and HSV-1 reactivation from latency 
was blocked by inhibiting the H3K9me3 histone demethylase 
LSD1 (Liang et  al., 2009). H3K9me3 was also enriched on 
the latent gammaherpesvirus EBV genome, whereas relatively 
low levels of H3K27me3 were found (Day et al., 2007; Tempera 
and Lieberman, 2010). In contrast, Cliffe et al. (2009) identified 
H3K27me3 as the most enriched histone mark on the latent 
HSV-1 genome. For the HHV-6A genome, both H3K27me3 
and H3K9me3 exhibit similar patterns of enrichment, with 
the exception of the increased H3K27me3 signal in the viral 
direct repeat regions. Although this is an interesting outcome, 
the biological relevance of this observation currently 
remains unknown.
CONCLUSIONS
This study provides an unbiased integrative genomics approach 
toward uncovering the chromatin profile in patient-derived 
iciHHV-6 and experimentally infected 293-HHV-6A cell lines. 
Our results demonstrate that chromosomally integrated HHV-6A 
is completely transcriptionally silent, resides in a heterochromatic 
state, and is associated with H3K9me3 and H3K27me3 repressive 
histone modifications. Although we  were unable to reactivate 
HHV-6A in the current study, it can be speculated that HHV-6A 
reactivation would alter the transcriptional state and that 
nucleosome occupancy would decrease across active regions 
of the viral genome. The lack of detectable viral associated 
transcripts and miRNAs in our analysis suggests that the 
mechanism underlying HHV-6A latency may differ significantly 
from those observed with other herpesviruses, e.g., HSV-1. 
Taken together, our data highlight how histone modifications 
and chromatin condensation play an important role in the 
control of the integrated HHV-6A genome and represent the 
baseline for further analysis to uncover epigenetic state during 
integration and reactivation.
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